HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gargi D Basu Selected Research

Drug Therapy (Chemotherapy)

1/2009Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.
7/2008Functional evidence implicating S100P in prostate cancer progression.
11/2004Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gargi D Basu Research Topics

Disease

13Neoplasms (Cancer)
01/2022 - 01/2004
6Breast Neoplasms (Breast Cancer)
08/2006 - 01/2004
4Adenocarcinoma
01/2009 - 01/2004
3Pancreatic Neoplasms (Pancreatic Cancer)
06/2009 - 03/2007
2Disease Progression
08/2021 - 12/2014
1Brain Neoplasms (Brain Tumor)
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Microsatellite Instability
04/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
09/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2010
1Alzheimer Disease (Alzheimer's Disease)
01/2010
1Dementia (Dementias)
01/2010
1Prostatic Neoplasms (Prostate Cancer)
07/2008
1Neoplasm Metastasis (Metastasis)
08/2006
1Necrosis
01/2005

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
04/2021 - 11/2004
5Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2009 - 11/2004
5Celecoxib (Celebrex)FDA Link
01/2009 - 11/2004
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2008 - 03/2004
4Small Interfering RNA (siRNA)IBA
09/2010 - 01/2006
3Phosphotransferases (Kinase)IBA
09/2010 - 06/2009
2RNA (Ribonucleic Acid)IBA
01/2022 - 08/2021
2Biomarkers (Surrogate Marker)IBA
12/2014 - 07/2008
2PD 407824IBA
09/2010 - 06/2009
2GemcitabineFDA Link
06/2009 - 01/2009
2VaccinesIBA
01/2009 - 08/2006
2Dinoprostone (PGE2)FDA Link
01/2005 - 03/2004
1DNA (Deoxyribonucleic Acid)IBA
04/2021
1NucleotidesIBA
04/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1Biological ProductsIBA
12/2014
1Immune Checkpoint ProteinsIBA
12/2014
1LigandsIBA
12/2014
1Cisplatin (Platino)FDA LinkGeneric
09/2010
1Indicators and Reagents (Reagents)IBA
06/2010
1CaspasesIBA
06/2010
1AntibodiesIBA
06/2010
1Rituximab (Mabthera)FDA Link
06/2010
1tau Proteins (tau Protein)IBA
01/2010
1SB 218078IBA
06/2009
1Mucin-1 (CA 15-3 Antigen)IBA
01/2009
1MucinsIBA
09/2008
1Glycoproteins (Glycoprotein)IBA
09/2008
1CamptothecinIBA
07/2008
1Androgen Receptors (Androgen Receptor)IBA
07/2008
1Hormones (Hormone)IBA
07/2008
1Proteins (Proteins, Gene)FDA Link
07/2008
1Cancer VaccinesIBA
08/2006
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2005
1Tumor Viral Antigens (Large T Antigen)IBA
11/2004
1Neoplasm Antigens (Tumor Antigens)IBA
01/2004

Therapy/Procedure

8Therapeutics
08/2021 - 03/2004
3Drug Therapy (Chemotherapy)
01/2009 - 11/2004
2Immunotherapy
01/2021 - 03/2004
1Precision Medicine
01/2022
1Radiotherapy
11/2004
1Oral Administration
11/2004